CCD is committed to helping as many people as possible, as soon as possible, reverse their chronic conditions. Structuring CCD as a non-profit allows us to singularly focus on our mission instead of returning financial value to shareholders. We can avoid revenue models such as premium launch pricing or limited releases to recoup research and development costs. These pricing strategies and reliance on third-party payers (insurance companies, employers, and government) are barriers to widespread, rapid adoption.